Sutent Rechallenge In mRCC Patients

CompletedOBSERVATIONAL
Enrollment

61

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Metastatic Renal Cell Carcinoma
Interventions
OTHER

sunitinib: observational study

Observational study evaluating patients who were treated with sunitinib in 1st line and in 3rd line

Trial Locations (18)

13335

CHU de la Timone, Marseille

13385

Hopital Timone Adultes, Marseille

31000

Institut Claudius Regaud, Toulouse

33075

Hôpital Saint-André, Bordeaux

35042

Centre Eugene Marquis, Rennes

38043

Hopital albert Michalon, Grenoble

42271

Departement d'Oncologie Medicale-Institut de Cancerologie de la Loire, Saint-Priest-en-Jarez

44805

Centre Rene Gauducheau - Service Oncologie Medicale, Saint-Herblain

49100

Centre Paul Papin, Angers

54511

Centre Alexis Vautrin, Vandœuvre-lès-Nancy

59020

Centre Oscar Lambret - Cancérologie Urologie Digestive, Lille

59042

clinique de la Louvière, Lille

66330

Centre Catalan Urologie Andrologie, Cabestany

69373

Centre Leon Berard, Service d'Oncologie Medicale, Lyon

75908

Hopital Europeen Georges Pompidou, Paris

76031

CHU Charles Nicolle, Rouen

87042

Hopital Dupuytren - Oncologie Medicale, Limoges

13273 Cedex 9

Institut Paoli-Calmettes / Hôpital de jour, Marseille

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01827254 - Sutent Rechallenge In mRCC Patients | Biotech Hunter | Biotech Hunter